Youcare Pharmaceutical Group Co. Ltd. A Total Assets
Youcare Pharmaceutical Group Co. Ltd. A total assets. Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) holds total assets worth CN¥5.05 Billion CNY (≈ $738.86 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 688658 company net worth for the company's overall valuation and market capitalisation.
Total Assets of Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)
Total assets of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025. This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. See today's stock price for Youcare Pharmaceutical Group Co. Ltd. A for real-time trading data and today's change.
Youcare Pharmaceutical Group Co. Ltd. A - Asset Composition Analysis
Youcare Pharmaceutical Group Co. Ltd. A Total Assets Breakdown (December 2025)
Youcare Pharmaceutical Group Co. Ltd. A total assets breakdown as of December 2025. Youcare Pharmaceutical Group Co. Ltd. A's total assets of CN¥5.05 Billion consist of 49.7% current assets and 50.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 19.6% |
| Accounts Receivable | CN¥646.01 Million | 12.4% |
| Inventory | CN¥465.11 Million | 8.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥443.26 Million | 8.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 688658 working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Youcare Pharmaceutical Group Co. Ltd. A's current assets represent 49.7% of total assets in 2025, a decrease from 56.3% in 2017.
- Cash Position: Cash and equivalents constituted 19.6% of total assets in 2025, down from 22.6% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 5.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 12.4% of total assets.
Youcare Pharmaceutical Group Co. Ltd. A Competitors by Total Assets
Key competitors of Youcare Pharmaceutical Group Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $10.03 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $752.18 Million |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Verona Pharma PLC ADR
NASDAQ:VRNA
|
USA | $572.87 Million |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
Youcare Pharmaceutical Group Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.98 | 1.98 | 2.71 |
| Quick Ratio | 1.65 | 1.55 | 2.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.22 Billion | CN¥1.31 Billion | CN¥2.25 Billion |
Youcare Pharmaceutical Group Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Youcare Pharmaceutical Group Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.73 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | -9.3% |
| Total Assets | CN¥5.21 Billion |
| Market Capitalization | $757.27 Million USD |
Valuation Analysis
Below Book Valuation: The market values Youcare Pharmaceutical Group Co. Ltd. A's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Youcare Pharmaceutical Group Co. Ltd. A's assets decreased by 9.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)
The table below shows the annual total assets of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.21 Billion ≈ $761.98 Million |
-9.25% |
| 2024-12-31 | CN¥5.74 Billion ≈ $839.67 Million |
-2.93% |
| 2023-12-31 | CN¥5.91 Billion ≈ $865.01 Million |
-1.62% |
| 2022-12-31 | CN¥6.01 Billion ≈ $879.23 Million |
+4.92% |
| 2021-12-31 | CN¥5.73 Billion ≈ $838.01 Million |
+4.94% |
| 2020-12-31 | CN¥5.46 Billion ≈ $798.53 Million |
+57.39% |
| 2019-12-31 | CN¥3.47 Billion ≈ $507.36 Million |
+1.43% |
| 2018-12-31 | CN¥3.42 Billion ≈ $500.21 Million |
-2.46% |
| 2017-12-31 | CN¥3.50 Billion ≈ $512.80 Million |
-- |
About Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder injection, pills, tablets, capsules, ointments, creams, granules, etc. The company provides drugs in various categories, including covering cardio-cerebrovascular, antivirals, central… Read more